Business
The big winners of the tech wreck are biopharma stocks
The shares of large drugmakers like Lilly, Gilead and J&J keep hitting record highs.
- Published
- (1 h ago)
- Outlet
- MarketWatch
- Section
- Business
- Length here
- Headline and 14-word snippet. The full article is at the source.
More from MarketWatch and around the same time
Microsoft is winning the cloud wars and becoming Wall Street’s new golden childVarious factors indicate that Microsoft is in a better financial position than its cloud rivals, analysts say.American workers are finding their take-home pay isn’t keeping up with inflation, with their wallets ‘stretched thinner and thinner’Worker compensation grows slower than inflation for second straight quarterYou can expect the stock market to rally no matter who wins on Election DayAlso in Weekend Reads: Dividend stocks, a way to jump on the Anthropic bandwagon ahead of its IPO, and advice from The Moneyist.After Intel’s historic stock drop, analysts say there’s no reason to buy the dip“A cheaper stock does not necessarily offer better value,” one expert says.Trump administration is illegally delaying student-debt forgiveness for tens of thousands of public servants, lawsuit allegesTeachers, nurses and other borrowers have waited years for approval to complete their payment obligation and access debt relief, the suit claims.Private equity in your 401(k)? Heed Warren Buffett’s warningAbout 52% of people with a workplace retirement plan say they would invest in private assets if they were available in their company’s plan.This page holds the headline and a short snippet as published by MarketWatch, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
